The World Muscle Society is delighted to invite you to attend the 27th International Hybrid Annual Congress of the World Muscle Society that will take place 11th – 15th October 2022, in Halifax, Nova Scotia, Canada. The congress venue is the Halifax Convention Centre at 1650 Argyle Street, in the heart of this Atlantic seaport. We will also be making the presentations and e-posters available via our platform and app for delegates who wish to attend virtually. We are working hard to ensure that the registration process is as flexible as possible as we all navigate these ever changing and uncertain times.
Halifax is famous for its Maritime hospitality, and it is a walkable city with vibrant historic streets and many museums. Halifax Stanfield International Airport has numerous daily connections to major cities across Canada and the USA, as well as several direct flights to Europe. Please review the current information regarding travel to Canada and Nova Scotia which is available on our Information section of the Congress website prior to planning your travel. As always, the health and safety of our community is of the utmost importance to us. For information about current public health and safety measures, please review our Information section of the Congress website.
The academic and clinical teams from the Hospital for Sick Children and University of Toronto led by Jim Dowling and Jiri Vajsar, together with the Local Organising Committee and the WMS Programme Committee, are the hosts and organisers of this meeting. The 5-day meeting will be an opportunity to catch up on the latest developments in neuromuscular diseases from around the world.
Following the longstanding tradition of the WMS, the meeting will be preceded by a teaching course, on 9-11th October 2022, at the IWK Health Centre in Halifax.
Contributions about new advances across the neuromuscular field are very welcome. The main thematic topics that will be addressed in the plenary sessions are :
1. New Developments in Congenital Muscle Disease
2. Neuropathies and Non-5q Motor Neuron Disease
3. The Development of Therapeutic Approaches